Search

everythinglearnresearchcommunity

for

Search:↓

Gender-affirming hormone therapy changes hair growth in transgender people, with feminizing therapy reducing hair and masculinizing therapy increasing it, but sometimes additional treatment is needed.

Blocking SCD1 in the skin with XEN103 shrinks sebaceous glands in mice.

Clomiphene citrate is a cheap and simple treatment for low testosterone that works as well as human chorionic gonadotropin, alone or combined, especially for men who want to keep their fertility.

A 15-year-old girl with rare reproductive disorders received hormone therapy to develop secondary sexual traits, but infertility persisted.

Hirsutism treatment should focus more on patient needs and quality of life.

Targeting androgen receptors with antiandrogen oligonucleotides could effectively treat hair loss.

Finasteride and dutasteride are equally effective and safe for treating benign prostatic hyperplasia.

The therapies improved ejaculation disorders and sexual function in middle-aged men.

Leuprolide plus estrogen is more effective than oral contraceptives for reducing hirsutism.

Properly administered testosterone therapy is safe and effective but often not covered by insurance.

New compounds may help treat prostate issues without affecting androgen receptors.

Finasteride, CPA, and flutamide are all equally effective in reducing excessive hair growth in women.

Testosterone replacement therapy can prevent men from fathering children and should not be used by those wanting to stay fertile.

Hirsute women have lower type 2 17β-HSD enzyme levels, which improve with treatment.

AR-27 E-Chol siRNA can effectively regrow hair by reducing androgen receptor gene activity.

LY191704 is a compound that effectively blocks a specific enzyme involved in hormone conversion and could help treat enlarged prostate and hair loss.

PF-998425 is a new, effective, and non-phototoxic treatment for skin conditions related to androgens.

Researchers developed new compounds that target the androgen receptor effectively with fewer side effects.

Men with isolated hypogonadotropic hypogonadism have partial steroid deficiencies, while those with panhypopituitarism have severe deficiencies.

Ovarian steroid cell tumors should be considered in adults with hirsutism and high testosterone, with surgery as the main treatment.

Testosterone therapy can improve skin and hair in men with low testosterone but may cause skin irritation with certain treatments.

Testosterone replacement is recommended for men with low testosterone levels and symptoms of hypogonadism.

RU58841, a substance from France, can potentially block the effects of hormones that cause hair loss and excessive hair growth, performing better than a similar substance, cyproterone acetate.

Selective Androgen Receptor Modulators (SARMs) are drugs that can control the effects of androgens in different tissues, potentially having fewer side effects and promising for treating various conditions.

Certain compounds reduced hamster flank organ size by inhibiting 5α-reductase, like finasteride, without affecting androgen receptors.

A postmenopausal woman's increased male hormone levels were successfully treated with surgery.

Testosterone therapy seems safe for short-term use in postmenopausal women with low sexual desire, but more research on long-term effects is needed.

Cyproterone acetate is effective for treating hirsutism and acne in women by blocking androgens in the skin and also works as a contraceptive.